Biography:
Huiyu Xu, Ph.D. (Peking Univ., 2011), heads the Endocrine Laboratory at Peking University Third Hospital’s Reproductive Center. As a member of ASPIRE’s AI SIG Group, she has published 40+ SCI papers (30+ first‑author) and holds over 20 national and PCT patents, many commercialized. Awards include the 2021 Maternal & Child Health Sci‑Tech First Prize and the 2019 MOE (Ministry of Education) Sci‑Tech Progress Second Prize. She co‑developed OvaRePred—the world’s first ovarian reserve assessment and perimenopause prediction tool—selected among The Innovation journal ’s Top 10 Innovation focus in 2023 and licensed to Heronova, a US company.
Title : Empowering early intervention: AI-based ovarian reserve screening and menopause prediction via OvaRePred
Title : Streamlining PCOS identification: A user-friendly AI tool for early screening